CD8A and melanoma: Dexosomes released by such prepared DCs (Dexo(B16 + pIC)) have shown higher potential to induce strong activation of melanoma-specific CD8+ T cells and recruit cytotoxic CD8+Tcells, NK, and NK-T cells to the tumor site.